Skip to main content
. 2013 Jun 10;7:1093–1098. doi: 10.2147/OPTH.S43939

Figure 3.

Figure 3

Surgical dissection in patient-A of fibrotic encapsulation of fluocinolone acetonide implant (Retisert™, Bausch & Lomb, Rochester, NY, USA). (A) Diagram detailing the dimensions of the fluocinolone acetonide implant. The dotted red lines indicate the placement and orientation of incisions created in the surrounding fibrotic capsule with a microvitreoretinal (MVR) blade. (B) The vitreous cutter was used to debulk any residual vitreous surrounding the fibrotic capsule. (C and D) The MVR blade was used to incise the fibrotic capsule, taking care to avoid contact with the delicate membrane of the implant. (EG) Intraocular forceps were used to grasp the cut edge of the membrane and peel the membrane from the surface of the implant. (H) The MVR blade was used once more to ensure that all surrounding membranes were incised. (I, J) The vitreous cutter was used to trim and excise any residual capsule, revealing the drug capsule.

Abbreviations: FA, fluocinolone acetonide; PCIL,posterior chamber intraocular lens; Vit, vitreous.